日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

[Efficacy and safety analysis of BTK inhibitors combined with R-CHOP regimen in newly diagnosed double-expressor diffuse large B-cell lymphoma]

[BTK抑制剂联合R-CHOP方案治疗新诊断的双表达弥漫性大B细胞淋巴瘤的疗效和安全性分析]

Lu, J B; Cao, L; Liu, H L; Miao, Y; Shen, H R; Xia, Y; Yin, H; Cheng, Y X; Li, J Y; Fan, L

Correction to "Photocatalytic Pt(IV)-Coordinated Carbon Dots for Precision Tumor Therapy"

对“用于精准肿瘤治疗的光催化Pt(IV)配位碳点”的更正

Guo, D; Lei, J H; Rong, D; Zhang, T; Zhang, B; Tang, Z; Shen, H-M; Deng, C-X; Qu, S

Multi-assistant methods improve stromal tumor-infiltrating lymphocytes (sTILs) assessment in breast cancer: results of multi-institutional ring studies

多辅助方法可提高乳腺癌基质肿瘤浸润淋巴细胞(sTILs)的评估准确性:多中心环形研究的结果

Zhao, M; Dong, P; Li, Z; Li, J; Wu, S; Xing, H; Zhang, P; Zhang, J; Shen, H; Yang, H; Yang, W; Han, X; Liu, Y

[Renal response and prognosis of newly diagnosed patients with multiple myeloma with renal impairment applying VRD and autologous hematopoietic stem cell transplantation]

[应用VRD方案和自体造血干细胞移植治疗新诊断的肾功能受损的多发性骨髓瘤患者的肾脏反应和预后]

Wu, X Y; Huang, Y; Shen, H M; You, H Y; Yan, Z; Xie, Y; Yao, W Q; Yan, S; Wang, J; Zhai, Y Y; Shi, X L; Shang, J J; Jin, S; Yan, L Z; Wu, D P; Fu, C C

[Efficacy and safety of PEMD regimen in newly diagnosed early-stage non-upper respiratory digestive tract or advanced extranodal natural killer/T-cell lymphoma]

[PEMD方案治疗新诊断的早期非上呼吸道消化道或晚期结外自然杀伤/T细胞淋巴瘤的疗效和安全性]

Zhang, X Y; Du, K X; Shen, H R; Wu, J Z; Li, Y; Yin, H; Wang, L; Liang, J H; Li, J Y; Xu, W

[Efficacy and safety of chimeric antigen receptor T-cell therapy followed by allogeneic hematopoietic stem cell transplantation in 21 patients with Ph-like acute lymphoblastic leukemia]

[嵌合抗原受体T细胞疗法联合异基因造血干细胞移植治疗21例Ph样急性淋巴细胞白血病患者的疗效和安全性]

Dai, H P; Shen, H J; Li, Z; Cui, W; Cui, Q Y; Li, M Y; Chen, S F; Zhu, M Q; Wu, D P; Tang, X W

[Efficacy and safety analysis of P-GemDOx regimen and stratified prognosis in patients with early extranodal NK/T cell lymphoma]

[P-GemDOx方案治疗早期结外NK/T细胞淋巴瘤患者的疗效和安全性分析及分层预后]

Xing, T Y; Wang, W T; Shen, H R; Wu, J Z; Yin, H; Li, Y; Wang, L; Liang, J H; Li, J Y; Xu, W

[Efficacy and safety analysis of the OR-CHOP regimen for the treatment of MCD subtype diffuse large B cell lymphoma in the real-world setting]

[OR-CHOP方案治疗MCD亚型弥漫性大B细胞淋巴瘤在真实世界中的疗效和安全性分析]

Yin, H; Hua, W; Shen, H R; Wu, J Z; Li, Y; Wang, L; Liang, J H; Li, J Y; Xu, W

[Clinical analysis of 7 cases of acute B cell lymphoblastic leukemia with t (17;19) (q21-22;p13)/TCF3-HLF fusion]

[7例t(17;19)(q21-22;p13)/TCF3-HLF融合的急性B细胞淋巴母细胞白血病的临床分析]

Pu, Y; Liu, Y; Zhou, X Y; Song, B Q; Zhang, J; Yan, W H; Wang, Q; Cen, J N; Shen, H J; Wang, Q R; Chen, S N; Pan, J L; Qiu, H Y

[The efficacy and safety of thioamide in maintenance therapy for peripheral T-cell lymphoma]

【硫代酰胺在维持治疗外周T细胞淋巴瘤中的疗效和安全性】

Yin, H; Liang, J H; Wu, J Z; Li, Y; Zhang, X Y; Kong, Y L; Pan, B H; Wang, L; Li, J Y; Xu, W; Shen, H R